Skip to main content

Table 3 Drug selection count and fault coverage

From: Application of Max-SAT-based ATPG to optimal cancer therapy design

Drug Vector

Count

Coverage

Drug Vector

Count

Coverage

000001

3

23%

000111

13

100%

000010

2

15%

001011

6

46%

000100

2

15%

001101

6

46%

001000

1

8%

001110

10

77%

010000

2

15%

010011

7

54%

100000

3

23%

010101

7

54%

000011

5

38%

010110

10

77%

000101

3

23%

011001

6

46%

000110

10

77%

011010

5

38%

001001

4

31%

011100

5

38%

001010

3

23%

100011

8

62%

001100

3

23%

100101

8

62%

010001

5

38%

100110

10

77%

010010

4

31%

101001

7

54%

010100

4

31%

101010

6

46%

011000

3

23%

101100

6

46%

100001

6

46%

110001

6

46%

100010

5

38%

110010

5

38%

100100

5

38%

110100

5

38%

101000

4

31%

111000

4

31%

110000

3

23%

   
  1. The drug vectors are grouped according to the number of drugs selected (1, 2, or 3 drugs). The count column notes the number of testable faults rectified by the drug selection, and the coverage shows the count as a percentage of total testable fault rectified. Bold rows indicate drug vectors with highest coverage for the number of drugs used.